IGWM
NVAX icon

ICA Group Wealth Management’s Novavax NVAX Stock Holding History

ICA Group Wealth Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-200
Closed -$960 – 1402
2023
Q4 		$960 Buy
+200
New +$1.22K ﹤0.01% 1233
2023
Q3 		– Sell
-200
Closed -$1.49K – 868
2023
Q2 		$1.49K Hold
200
– – ﹤0.01% 1160
2023
Q1 		$1.39K Hold
200
– – ﹤0.01% 1123
2022
Q4 		$2.06K Buy
+200
New +$3.53K ﹤0.01% 1101

Other funds holding NVAX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

ICA Group Wealth Management's NVAX Position: Q1 2024 in Review

ICA Group Wealth Management sold out of Novavax (NVAX) in Q1 2024, closing a stake of 200 shares — an estimated $960 sold.

ICA Group Wealth Management first reported a position in NVAX in Q4 2022 and held it in 4 quarters. The position peaked at $2.06K in Q4 2022. 201 funds tracked by Wall St. Rank hold NVAX as of Q1 2024.

  • ICA Group Wealth Management reported no remaining Novavax position as of Q1 2024 after selling out during the quarter.
  • ICA Group Wealth Management sold 200 Novavax shares in Q1 2024, an estimated $960.
  • ICA Group Wealth Management first reported a position in Novavax in Q4 2022 and held it in 4 quarters.
  • ICA Group Wealth Management's Novavax position peaked at $2.06K in Q4 2022.
  • 201 funds tracked by Wall St. Rank held Novavax as of Q1 2024.

Based on ICA Group Wealth Management's 13F filing for Q1 2024, filed 14 May 2024.